期刊文献+

靶向转酮醇酶样基因1 siRNA表达载体的构建及鉴定 被引量:3

Construction and identification of siRNA expression vectors for silencing transketolase-like gene 1
下载PDF
导出
摘要 目的构建针对转酮醇酶样基因1(TKTL1)特异性小干扰RNA(siRNA)真核表达载体并检测其沉默效应。方法采用人U6 SnRNA启动子,分别把被9 bp序列间隔的19 bp长短的TKTL1靶序列的反向重复序列,置于pEGFP-C1-U6质粒载体中,构建成TKTL1短发夹环RNA,产生重组质粒pEGFP-C1-U6/TKTL1,分别用PstⅠ和SalⅠ酶切鉴定及测序分析,并将重组质粒转染人结肠癌细胞株LoVo,通过RT-PCR检测TKTL1基因表达水平的变化。结果酶切鉴定与DNA测序分析证明,TKTL1基因的siRNA表达载体构建正确,RT-PCR结果表明转染重组质粒的LoVo细胞TKTL1基因的表达水平明显降低。结论成功构建了针对TKTL1基因的siRNA表达载体,转染LoVo细胞后可显著抑制TKTL1基因表达。 Objective To construct specific small interfering RNA (siRNA) expression vectors of transketolase-like gene 1 and to detect the silencing effects. Methods A plasmid pEGFP-CI-U6/TKTL1 containing human U6 snRNA promoter was ligated to a 19 bp reverse repeated motif of TKTL1 target sequence with 9 bp spacer. The recombinant pEGFP-C1-U6/TKTL1 plasmids were identified by restriction endonuclease (Psi II and Sal I ) and DNA sequencing, and then transferred into LoVo cell line. The level of TKTLl mRNA was examined by real-time PCR. Results The TKTL1 short hairpin RNA (shRNA) expression frame was successfully inserted into expression vector. Enzyme digestion by Pst I and Sal I showed a 400 bp DNA fragment. The sequence of shRNA recombinant plasmid was the same as that of the designed fragment. Conclusions Expression vectors of shRNA specific for TKTL1 were constructed. The expression of TKTL1 mRNA in LoVo cell line transfected by recombinant pEGFP-C1-U6/TKTL1 plasmids was reduced significantly.
出处 《临床检验杂志》 CAS CSCD 北大核心 2010年第2期128-130,共3页 Chinese Journal of Clinical Laboratory Science
关键词 SIRNA 转酮醇酶 转酮醇酶样基因1 人结肠癌细胞株LoVo small interfering RNA transketolase-like gene 1 LoVo cell line
  • 相关文献

参考文献7

  • 1Xu X, Zur Hausen A, Coy JF, et al. Transketolase-like protein 1 ( TKTL1 ) is required for rapid cell growth and full viability of human tumor cells[J]. Int J Cancer, 2009, 124(6) : 1330-1337.
  • 2Staiger WI, Coy JF, Grobholz R, et al. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer[ J]. Oncol Rep, 2006,16(4) :657-661.
  • 3Frederiks WM, Vizan P, Bosch KS, et al. Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre) neoplastic lesions in rat liver[J]. Int J Exp Pathol, 2008,89(4) :232-240.
  • 4Coy JF, Dressler D, Wilde J, et al. Mutations in the transketolase- like gene TKTL1 : clinical implications for neurodegenerative diseases, diabetes and cancer[J]. Clin Lab, 2005, 51 (5-6) : 257-273.
  • 5Rais B, Comin B, Puigjaner J, et al. Oxythiamine and dehydroepi- androsterone induce a G1 phase cycle arrest in Ehrlich's tumour cells through inhibition of the pentose cycle [ J]. FEBS Lett, 1999, 456 (1): 113-118.
  • 6Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells [ J ]. Proc Natl Aead Sci USA, 2002, 99(9) : 6047-6051.
  • 7Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference[J].JAMA, 2005, 293 ( 11 ) : 1367-1373.

同被引文献36

  • 1张德太,胡丽华,杨渝珍.去氢表雄酮及G6PD基因反义寡核苷酸对Raji细胞的某些影响[J].中国病理生理杂志,2006,22(12):2397-2400. 被引量:4
  • 2Huang LE, Arany Z, Livingston DM, et al. Activation of hypoxia - inducible transcription factor depends primarily upon redox sensitive stabilization of its alpha subunit [ J ].J Biol Chem, 1996,271 ( 50 ) :32253 - 32259.
  • 3Osada M, Imaoka S, Sugimoto T, et al. NADPH cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia - inducible factor 1 [ J ]. J Biol Chem,2002,277 (26) :23367 - 23373.
  • 4Ohl F, Jung M, Radonic A, et al. Identification and vali- dation of suitable endogenous reference genes for gene ex- pression studies of human bladder Cancer [ J ]. J Urol, 2006, 175(5): 1915-1920.
  • 5Frederiks WM, van Marie J,van Oven C, et al. Improved localization of glucose - 6 - phosphate dehydrogenase ac- tivity in cells with 5 - cyano - 2,3 - ditolyl - tetrazolium chloride as fluorescent redox dye reveals its cell cycle - dependent regulation [ J ]. J Histochem Cytochem, 2006, 54(1) : 47 -52.
  • 6Lopez - Lazaro M. HIF - 1 : hypoxia - inducible factor or dysoxia - inducible factor? [ J ]. FASEB J,2006,20 (5) : 828 - 832.
  • 7Tuttle SW, Maity A, Oprysko PR, et al. Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for the mechanism of HIF - 1α stabilization under moderate hypoxia[J]. J Biol Chem, 2007, 282 (51) :36790 -36796.
  • 8Swinson DE,Jones JL, Cox G, et al. Hypoxia - inducible factor-1α in non small cell lung Cancer: Relation to growth factor, protease and apoptosis pathways [ J ]. Int J Cancer,2004,111 ( 1 ) :43 -50.
  • 9Semenza GL. Development of novel therapeutic strategies that target HIF - 1 [ J ]. Expert Opin Ther Targets, 2006, 10(2) :267 - 280.
  • 10Langbein S, Frederiks WM, zur Hausen A, et al. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer[ J ]. Int J Cancer, 2008, 122 ( 11 ) :2422 -2428.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部